Biogen Foreign Currency Transaction Gain (Loss), Before Tax increased by 36.9% to -$6.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 271.1%, from $3.80M to -$6.50M.
nee_foreign_currency_transaction_gain_loss_before_tax| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$800.00K | -$13.70M | -$8.30M | -$19.20M | -$11.50M | -$10.70M | -$8.70M | -$11.40M | -$9.40M | -$11.30M | -$4.90M | $3.80M | -$10.40M | -$10.30M | -$6.50M |
| QoQ Change | — | <-999% | +39.4% | -131.3% | +40.1% | +7.0% | +18.7% | -31.0% | +17.5% | -20.2% | +56.6% | +177.6% | -373.7% | +1.0% | +36.9% |
| YoY Change | — | — | — | <-999% | +16.1% | -28.9% | +54.7% | +0.9% | +12.1% | -29.9% | +57.0% | +140.4% | +8.0% | -110.2% | -271.1% |